+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cervical Dysplasia Market (2022-2027) by Diagnostics Type, Treatment Type, End-users, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis

  • PDF Icon


  • 175 Pages
  • July 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5650842

An increase in the number of awareness campaigns for the early diagnosis of the disease is anticipated to fuel the growth of the market for cervical dysplasia during the forecast period

The Global Cervical Dysplasia Market is estimated to be worth USD 704.34 million in 2022, and is expected to reach USD 977.76 million by 2027, growing at a CAGR of 6.78%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentation

The Global Cervical Dysplasia Market is segmented based on Diagnostics Type, Treatment Type, End-users, and Geography.
  • By Diagnostics Type, the market is classified into Biopsy, Colposcopy, HPV Test, and Pap Smear Test.
  • By Treatment Type, the market is classified into Chemotherapy, Radiation Therapy, Surgery, and Therapeutic HPV Vaccines.
  • By End-users, the market is classified into Ambulatory Surgery Centers, Diagnostic Centers, Hospitals, Research & Academic Institutes, and Specialty Clinics.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, Asieris Pharmaceuticals, ASKA Pharmaceutical Co., Ltd., Becton, Dickinson and Company, BetterLife Pharma, Inc., Bristol-Myers Squibb Company, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

The Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Cervical Dysplasia Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The Global Cervical Dysplasia Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.

Why Buy This Report?

  • The report offers a comprehensive evaluation of the Global Cervical Dysplasia Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel within the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario within the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules & regulations imposed on this sector across various geographies.
  • The report also contains competitive analysis using 'Positioning Quadrants'; a proprietary competitive positioning tool.

Report Highlights

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Cervical Dysplasia Market

What is the estimated value of the Global Cervical Dysplasia Market?

The Global Cervical Dysplasia Market was estimated to be valued at $704.34 Million in 2022.

What is the growth rate of the Global Cervical Dysplasia Market?

The growth rate of the Global Cervical Dysplasia Market is 6.7%, with an estimated value of $977.76 Million by 2027.

What is the forecasted size of the Global Cervical Dysplasia Market?

The Global Cervical Dysplasia Market is estimated to be worth $977.76 Million by 2027.

Who are the key companies in the Global Cervical Dysplasia Market?

Key companies in the Global Cervical Dysplasia Market include Abbott Laboratories, Asieris Pharmaceuticals, ASKA Pharmaceutical Co. Ltd., Becton, Dickinson, and Company, BetterLife Pharma, Inc., Bristol, Myers Squibb Company, Cardinal Health, Inc., CooperSurgical, Inc. and DYSIS Medical Ltd..

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Proprietary Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Incidences of Cervical Cancer
4.1.2 Rising Initiatives by the Government to Enhance the Screening of Cervical Dysplasia
4.1.3 Emergence of Cervical Screening Programs
4.2 Restraints
4.2.1 High Cost of Diagnostic Devices
4.3 Opportunities
4.3.1 Increasing Awareness Campaigns for the Early Diagnosis
4.3.2 Technological Advancements in Screening Devices and Other Supporting Equipment
4.4 Challenges
4.4.1 Alteration in Regulatory Guidelines for Cervical Cancer Screening and Use of HPV Vaccines
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Cervical Dysplasia Market, by Diagnostics Type
6.1 Introduction
6.2 Biopsy
6.3 Colposcopy
6.4 HPV Test
6.5 Pap Smear Test
7 Global Cervical Dysplasia Market, by Treatment Type
7.1 Introduction
7.2 Chemotherapy
7.3 Radiation Therapy
7.4 Surgery
7.5 Therapeutic HPV Vaccines
8 Global Cervical Dysplasia Market, by End-users
8.1 Introduction
8.2 Ambulatory Surgery Centers
8.3 Diagnostic Centers
8.4 Hospitals
8.5 Research & Academic Institutes
8.6 Specialty Clinics
9 Americas’ Cervical Dysplasia Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe’s Cervical Dysplasia Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe
11 Middle East and Africa’s Cervical Dysplasia Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA
12 APAC’s Cervical Dysplasia Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 Abbott Laboratories
14.2 Asieris Pharmaceuticals
14.3 ASKA Pharmaceutical Co. Ltd.
14.4 Becton, Dickinson, and Company
14.5 BetterLife Pharma, Inc.
14.6 Bristol-Myers Squibb Company
14.7 Cardinal Health, Inc.
14.8 CooperSurgical, Inc.
14.9 DYSIS Medical Ltd.
14.10 F. Hoffmann La-Roche Ltd.
14.11 GlaxoSmithKline PLC
14.12 Guided Therapeutics, Inc.
14.13 Helix BioPharma Corp.
14.14 Hologic, Inc.
14.15 Karl Kaps GmbH & Co. KG
14.16 KinoPharma, Inc.
14.17 Micromedic Technologies Ltd.
14.18 OncoHealth Corp.
14.19 PDS Biotechnology Company
14.20 Polaris Pharmaceuticals, Inc.
14.21 Qiagen N.V.
14.22 Quest Diagnostics, Inc.
14.23 ViciniVax B.V.
15 Appendix
15.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • Asieris Pharmaceuticals
  • ASKA Pharmaceutical Co. Ltd.
  • Becton, Dickinson, and Company
  • BetterLife Pharma, Inc.
  • Bristol-Myers Squibb Company
  • Cardinal Health, Inc.
  • CooperSurgical, Inc.
  • DYSIS Medical Ltd.
  • F. Hoffmann La-Roche Ltd.
  • GlaxoSmithKline PLC
  • Guided Therapeutics, Inc.
  • Helix BioPharma Corp.
  • Hologic, Inc.
  • Karl Kaps GmbH & Co. KG
  • KinoPharma, Inc.
  • Micromedic Technologies Ltd.
  • OncoHealth Corp.
  • PDS Biotechnology Company
  • Polaris Pharmaceuticals, Inc.
  • Qiagen N.V.
  • Quest Diagnostics, Inc.
  • ViciniVax B.V.